Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions.

GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

Researchers looked at the nine people who had vision problems while using the drugs and is one of several that have ...

Two healthcare stocks that may or may not be boring, but that regardless look like strong growth stocks to invest in this ...

Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

Eli Lilly and Company (NYSE: LLY) announced results from the VIVID-2 open-label extension study ... trial. Zepbound® (tirzepatide) provided a 47% greater relative weight loss compared to Wegovy ...

Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...

Viking Therapeutics (NASDAQ: VKTX) shares exploded higher after the clinical-stage drugmaker announced successful results ...

The increase in weight loss with the higher dose was impressive, but still lower than has been achieved in clinical trials of Eli Lilly's rival obesity therapy Zepbound (tirzepatide), which helped ...

The US Food and Drug Administration (FDA) has declared an end to the shortage of tirzepatide, the active ingredient in Eli Lilly’s popular weight loss medication Zepbound and diabetes drug Mounjaro.

Ahead, experts explain what to know about drinking elderberry juice for weight loss. What did the study find connecting elderberry juice and weight loss? Researchers say study participants ...